ATE501731T1 - Melanocortin-rezeptor-bindende mimetibodies, zusammensetzungen, verfahren und verwendungen - Google Patents

Melanocortin-rezeptor-bindende mimetibodies, zusammensetzungen, verfahren und verwendungen

Info

Publication number: ATE501731T1
Authority: AT; Austria
Prior art keywords: methods; compositions; melanocortin receptor; mimetibodies; binding
Prior art date: 2004-10-25

Application number

AT05819741T

Other languages

English (en)

Inventor

Mark Cunningham

Vedrana Stojanovic-Susulic

Karyn O'neil

Chichi Huang

Jeffrey Luo

Original Assignee

Centocor Ortho Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-25

Filing date

2005-10-25

Publication date

2011-04-15

2005-10-25 Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc

2011-04-15 Application granted granted Critical

2011-04-15 Publication of ATE501731T1 publication Critical patent/ATE501731T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Obesity (AREA)
Hematology (AREA)
Neurology (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Biotechnology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT05819741T 2004-10-25 2005-10-25 Melanocortin-rezeptor-bindende mimetibodies, zusammensetzungen, verfahren und verwendungen ATE501731T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62196004P	2004-10-25	2004-10-25
PCT/US2005/038431 WO2006047535A2 (en)	2004-10-25	2005-10-25	Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number	Publication Date
ATE501731T1 true ATE501731T1 (de)	2011-04-15

Family

ID=36228385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05819741T ATE501731T1 (de)	2004-10-25	2005-10-25	Melanocortin-rezeptor-bindende mimetibodies, zusammensetzungen, verfahren und verwendungen

Country Status (29)

Country	Link
US (1)	US20060105951A1 (de)
EP (1)	EP1812046B1 (de)
JP (1)	JP2008517605A (de)
KR (1)	KR101255140B1 (de)
CN (1)	CN101437540B (de)
AT (1)	ATE501731T1 (de)
AU (1)	AU2005299440B2 (de)
BR (1)	BRPI0518411A2 (de)
CA (1)	CA2585287A1 (de)
CY (1)	CY1111486T1 (de)
DE (1)	DE602005026970D1 (de)
DK (1)	DK1812046T3 (de)
EA (1)	EA200700944A1 (de)
EC (1)	ECSP077416A (de)
ES (1)	ES2363023T3 (de)
HK (1)	HK1106445A1 (de)
HR (1)	HRP20110405T1 (de)
IL (1)	IL182683A0 (de)
MA (1)	MA28943B1 (de)
ME (1)	ME01234B (de)
MX (1)	MX2007004974A (de)
NO (1)	NO20072499L (de)
PL (1)	PL1812046T3 (de)
PT (1)	PT1812046E (de)
RS (1)	RS51789B (de)
SI (1)	SI1812046T1 (de)
TN (1)	TNSN07157A1 (de)
WO (1)	WO2006047535A2 (de)
ZA (1)	ZA200704260B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910101B2 (en) *	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) *	2005-10-07	2010-09-07	Codman & Shurtleff, Inc.	Implantable pump for protein delivery for obesity control by drug infusion into the brain
CA2727317C (en)	2008-06-09	2015-02-17	Palatin Technologies, Inc.	Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US20090305960A1 (en) *	2008-06-09	2009-12-10	Palatin Technologies, Inc	Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
US8614185B2 (en) *	2009-05-04	2013-12-24	Centocor Ortho Biotech Inc.	Fusion proteins of alpha-MSH derivatives and Fc
EA020959B1 (ru)	2009-06-08	2015-03-31	Палатин Текнолоджиз, Инк.	Пептиды, специфичные к меланокортиновым рецепторам
UY32690A (es)	2009-06-08	2011-01-31	Astrazeneca Ab	Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en)	2009-06-08	2010-12-16	Palatin Technologies, Inc.	Lactam-bridged melanocortin receptor-specific peptides
MX2012005862A (es)	2009-11-23	2012-09-07	Palatin Technologies Inc	Peptidos ciclicos especificos del receptor de melanocortina-1.
BR112012011780A2 (pt)	2009-11-23	2019-09-24	Palatin Technologies, Inc	peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP2020141710A (ja) *	2011-07-06	2020-09-10	ゲンマブエー／エス	抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) *	2019-03-02	2020-09-10	上海一宸医药科技有限公司	一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1137340A4 (de)	1998-12-09	2005-12-21	Eleanor Roosevelt Inst	Zusammensetzung und verfahren zur regulation des körpergewichtes und damit zusammenhängender zustände
EP1303625A2 (de) *	2000-07-14	2003-04-23	Zycos Inc.	Alpha-msh-verwandte verbindungen und verfahren zur verwendung davon
CA2490409A1 (en) *	2002-06-28	2004-01-08	Centocor, Inc.	Mammalian ch1 deleted mimetibodies, compositions, methods and uses
BR0312276A (pt) *	2002-06-28	2005-04-26	Centocor Inc	Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
WO2005097175A2 (en) *	2004-03-31	2005-10-20	Centocor, Inc.	Human glp-1 mimetibodies, compositions, methods and uses

2005
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 RS RS20110230A patent/RS51789B/en unknown
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 CA CA002585287A patent/CA2585287A1/en not_active Abandoned
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active IP Right Cessation
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es active Active
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/en active Application Filing
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/me unknown
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de active Active
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
- 2005-10-25 EP EP05819741A patent/EP1812046B1/de active Active
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
- 2007-11-05 HK HK07112011.3A patent/HK1106445A1/xx not_active IP Right Cessation
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown
- 2011-05-31 HR HR20110405T patent/HRP20110405T1/hr unknown

Also Published As

Publication number	Publication date
US20060105951A1 (en)	2006-05-18
ECSP077416A (es)	2007-05-30
ME01234B (me)	2013-06-20
HRP20110405T1 (hr)	2011-06-30
WO2006047535A2 (en)	2006-05-04
PL1812046T3 (pl)	2011-08-31
ZA200704260B (en)	2009-03-25
RS51789B (en)	2011-12-31
KR101255140B1 (ko)	2013-04-22
DK1812046T3 (da)	2011-06-06
EP1812046A4 (de)	2009-11-11
SI1812046T1 (sl)	2011-06-30
AU2005299440A1 (en)	2006-05-04
JP2008517605A (ja)	2008-05-29
MA28943B1 (fr)	2007-10-01
NO20072499L (no)	2007-07-16
EP1812046A2 (de)	2007-08-01
EP1812046B1 (de)	2011-03-16
TNSN07157A1 (en)	2008-11-21
IL182683A0 (en)	2007-09-20
ES2363023T3 (es)	2011-07-19
BRPI0518411A2 (pt)	2008-11-18
PT1812046E (pt)	2011-06-28
EA200700944A1 (ru)	2008-04-28
CY1111486T1 (el)	2015-08-05
DE602005026970D1 (de)	2011-04-28
CN101437540A (zh)	2009-05-20
KR20070085416A (ko)	2007-08-27
CN101437540B (zh)	2012-12-19
MX2007004974A (es)	2007-10-17
CA2585287A1 (en)	2006-05-04
AU2005299440B2 (en)	2011-12-15
WO2006047535A3 (en)	2008-09-04
HK1106445A1 (en)	2008-03-14

Publication	Publication Date	Title
TNSN07157A1 (en)	2008-11-21	Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2007041635A3 (en)	2008-11-13	Fc variants with optimized fc receptor binding properties
HUS1800021I1 (hu)	2018-06-28	Humán anti-Il-23 ellenanyagok, készítmények, eljárások és alkalmazások
MX2007013759A (es)	2008-04-29	Agentes de union de esclerostina.
TW200720076A (en)	2007-06-01	Composite materials and methods of making the same
DK1864132T3 (da)	2012-07-16	Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
WO2007014169A3 (en)	2007-05-10	Anti-cd26 antibodies and methods of use thereof
WO2006105338A3 (en)	2007-03-29	Fc VARIANTS WITH OPTIMIZED PROPERTIES
TW200611910A (en)	2006-04-16	Interferon-alpha polypeptides and conjugates
WO2006083276A3 (en)	2009-04-16	Interferon-alpha polypeptides and conjugates
TW200631594A (en)	2006-09-16	Toll like receptor 3 antagonists, methods and uses
WO2007051164A3 (en)	2007-11-29	Toll like receptor 3 modulators, methods and uses
TW200745159A (en)	2007-12-16	IL-6 binding proteins
NO20082240L (no)	2008-07-22	GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
WO2007044083A3 (en)	2009-04-16	Evolved interferon-alpha polypeptides
NO20055686L (no)	2007-06-04	Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
BRPI0506777A (pt)	2007-05-22	antagonistas do receptor muscarìnico da acetilcolina
MX2007011411A (es)	2007-11-13	Interaccion rage/diaphanous y composiciones relacionadas y metodos.
TW200720333A (en)	2007-06-01	Composite materials and methods of making the same
TW200711846A (en)	2007-04-01	Composite materials and methods of making the same
SG158098A1 (en)	2010-01-29	Toll like receptor 3 antagonists, methods and uses

Legal Events

Date	Code	Title	Description
2011-10-15	UEP	Publication of translation of european patent specification	Ref document number: 1812046 Country of ref document: EP

Date

Code

Title

Description

2011-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1812046

Country of ref document: EP